LivaNova Q4 revenue $310M (+12.8%), adj. EPS $0.87; full-year $1.15B; new CEO

LivaNova PLC

2023-FY EPS reported $0.32 revenue$1,153,545,000

Q4 revenue $310.1M, up 12.8% reported (11.9% constant currency) vs prior year.
Q4 GAAP diluted EPS $0.30; adjusted diluted EPS $0.87.
Full-year 2023 revenue $1.15B, up 12.9% reported (13.3% constant currency).
Full-year GAAP diluted EPS $0.32; adjusted diluted EPS $2.80, up 17% YoY.
Board named Vladimir A. Makatsaria CEO effective March 1, 2024; winding down Advanced Circulatory Support segment.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

LivaNova PLC reported quarter and full year ended December 31, 2023 results: revenue $310.1 million, EPS $0.30. Guidance initiated.

Period: quarter and full year ended December 31, 2023
Revenue: $310.1 million
EPS: $0.30
Guidance: initiated
Result: reported results

Exact text from the filing

Financial Summary and Highlights 1 • Fourth-quarter revenue of $310.1 million increased 12.8 percent on a reported basis and 11.9 percent on a constant-currency basis, as compared to the prior-year period • Fourth-quarter U.S.

View on SEC.gov

710 earnings releases filed in the last 30 days. Browse all earnings releases →

LivaNova PLC filing history →

Source: SEC EDGAR

accession 0001639691-24-000016

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.